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Abstract
Objective: Procalcitonin (PCT) and C reactive protein (CRP) have been used as infection
parameters. PCT increase correlates with the infection's severity, course, and mortality. Post-
cardiocirculatory arrest syndrome may be related to an early systemic inflammatory response, and
may possibly be associated with an endotoxin tolerance. Our objective was to report the time
profile of PCT and CRP levels after paediatric cardiac arrest and to assess if they could be use as
markers of immediate survival.
Materials and methods: A retrospective observational study set in an eight-bed PICU of a
university hospital was performed during a period of two years. Eleven children younger than 14
years were admitted in the PICU after a cardiac arrest. PCT and CRP plasma concentrations were
measured within the first 12 and 24 hours of admission.
Results: In survivors, PCT values increased 12 hours after cardiac arrest without further increase
between 12 and 24 hours. In non survivors, PCT values increased 12 hours after cardiac arrest with
further increase between 12 and 24 hours. Median PCT values (range) at 24 hours after cardiac
arrest were 22.7 ng/mL (0.2 – 41.0) in survivors vs. 205.5 ng/mL (116.6 – 600.0) in non survivors
(p < 0.05). CRP levels were elevated in all patients, survivors and non-survivors, at 12 and 24 hours
without differences between both groups.
Conclusion: Measurement of PCT during the first 24 hours after paediatric cardiac arrest could
serve as marker of mortality.
Background
Procalcitonin (PCT) and C reactive protein (CRP) have
been used as infection parameters. PCT concentration
increases because of several microbial infections and this
increase correlates with the infection's severity, course,
and mortality [1-5]. Other studies have shown low to only
moderately elevated PCT in uninfected patients after
major trauma, surgery and cardiogenic shock [6-8]. How-
ever, median values under these conditions are usually
below those found in severe sepsis and septic shock. Sev-
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vors, compared with survivors, after severe sepsis, cardiac
surgery or trauma patients [9-12].
Paediatric cardiac arrest is associated with high in-hospital
mortality [13]. Only one-third of children who suffer a
cardiac arrest when admitted to a Pediatric Intensive Care
Unit (PICU) survive. The duration of cardiopulmonary
resuscitation (CPR) attempts and the doses of epine-
phrine are the best indicators of mortality[14]. Adrie C et
al [15] found a marked increase in plasma cytokines of
patients successfully resuscitated after cardiac arrest, espe-
cially in nonsurvivors. Ischemic reperfusion injury is
closely related to neutrophils activated by cytokines.
Therefore, it has been hypothesized that post-cardiocircu-
latory arrest syndrome may be related to an early systemic
inflammatory response, leading to an exacerbation of the
inflammatory balance, and may possibly be associated
with an endotoxin tolerance. This condition has many
features in common with sepsis. Several biochemical var-
iables, including neuron specific enolase and interleukin-
8, have been described as biochemical markers of cerebral
damage [16].
A recent study has shown that PCT serum levels were sig-
nificantly higher in cardiac arrest patients who died of
refractory shock than in those who died of neurological
failure or survive[17]. There are not references in the liter-
ature about the correlation of both, PCT and CRP, and
mortality after cardiac arrest in children. Our objective
was to report the time profile of PCT and CRP levels after
paediatric cardiac arrest and to assess if they could be use
as markers of immediate survival.
Methods
A retrospective observational study set in an eight-bed
PICU of a university hospital was performed. During a
period of two years, eleven children younger than 14 years
were admitted in our PICU after a cardiac arrest. PCT and
CRP plasma concentrations were measured within the
first 12 and 24 hours of admission. Plasma CRP was meas-
ured on a Vitros 5.1 Fusion Chemistry System (Ortho
Clinical Diagnostics, Buckinghamshire, UK). For the
determination of PCT, time-resolved amplified cryptate
emission (TRACE) technology was used on a Kryptor ana-
lyzer (Brahms, Hennigsdorf, Germany). Limits of detec-
tion were 0.3 mg/dl and 0.02 ng/ml for CRP and PCT
methods, respectively. The study received ethics approval
by the Hospital Ethics Research Committee.
We compared CRP and PCT plasma levels among survivor
and non survivor patients. Mann-Whitney U-test was used
to compare two independent samples. A p-value ≤ 0.05
was considered significant.
Results
Eleven children, six males successfully resuscitated after
cardiac arrest were admitted in our PICU. Seven patients
survived and four did not survive at hospital discharge.
Age, diagnosis, place of arrest, cardiac arrest duration, out-
come and cause of death for each individual patient are
shown in Table 1. Children who died suffered out-hospi-
tal cardiac arrest of longer duration than children who sur-
vive.
Median PCT values (range) at 12 hours after cardiac arrest
were 23.6 ng/mL (3.1 – 78.2) and 79.1 ng/mL (32.8 –
300.8) in survivors and non survivors, respectively (p NS),
whereas at 24 hours were 22.7 ng/mL (0.2 – 41.0) and
Table 1: Patient characteristics, place of arrest, cardiac arrest duration, outcome and cause of death.
Case Age 
(months)
Diagnosis Place of 
arrest
Estimated time to initiation 
of CPR (minutes)
Time of 
CRA (minutes)
Outcome (hospital 
discharge)
Cause of death
1 162 Drowning Out-hospital 15 35 Death Brain death
2 42 Drowning Out-hospital 20 31 Death Withdrawal of care
3 5 Sudden death Out-hospital 10 30 Death Brain death
4 151 Drowning Out-hospital 15 50 Death Brain death
5 178 Ventricular arrytmia Out-hospital 1 7 Normal neurological 
function
Alive
6 8 Obstructive hydrocefalia In-hospital 0 3 Normal neurological 
function
Alive
7 6 Bronchiolitis In-hospital 0 4 Normal neurological 
function
Alive
8 2 Bronchiolitis In-hospital 0 3 Normal neurological 
function
Alive
9 21 Drowning Out-hospital 10 11 Neurological damage Alive
10 21 Pneumonia In-hospital 0 1 Normal neurological 
function
Alive
11 4 Heat stroke Hyperkaliemia In-hospital 0 8 Normal neurological 
function
Alive
CPR: cardiopulmonar resuscitation
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Box-plot of PCT plasma concentrations in the different groups. Data are presented in a logarithmic scale. Central line: 
median; boxes: 25th to 75th percentiles; whiskers: 95% confidence. P < 0.05 for PCT values at 24 hours between survivors and 
non survivors.
205.5 ng/mL (116.6 – 600.0) in survivors and non survi-
vors, respectively (p < 0.05). Median CRP values at 12
hours were 2.1 mg/dL (0.4 – 8.5) and 1.3 mg/dL (0.1 –
3.0) in survivors and non survivors, respectively (p NS)
whereas at 24 hours were 9.1 mg/dL (2.0 – 24.4) and 4.5
mg/dL (4.0 – 10.5) in survivors and non survivors, respec-
tively (p NS).
Figures 1 and 2 show box-plots of PCT and CRP plasma
concentrations in survivor and no survivor groups. In sur-
vivors, PCT values increased 12 hours after cardiac arrest,
without further increase between 12 and 24 hours. In non
survivors, PCT values increased 12 hours after cardiac
arrest with further increase between 12 and 24 hours.
Twenty-four hours after admission, PCT values were
higher than 100 ng/mL in non survivor patients, and
lower than 41 ng/mL in survivor patients (p < 0.05). CRP
levels were elevated in all patients, survivors and non-sur-
vivors 12 and 24 hours after admission without differ-
ences between both groups.
In spite of the reduced number of patients, it is interesting
to point out that time of cardiac arrest and time to initia-
tion of CPR were correlated with PCT values at 24 h (Fig-
ure 3). This relation was not found with 24 h PCR, since
similar PCR levels were observed regardless of these times
(Figure 4).
Discussion
We found in a small group of paediatric patients that PCT
levels higher than 100 ng/mL 24 hours after cardiac arrest
may identify high risk of mortality. Several studies have
demonstrated PCT utility for the diagnosis of severe bac-
terial infections[1-5,18]. Its plasma levels have also been
related with severity of sepsis[1,4,5,10,11,19]. Serial PCT
measurements are useful as a prognosis marker. A fall in
PCT after 24 hours of treatment may have favorable prog-
nostic significance [19]. On the other hand, increasing or
high PCT levels may indicate a poor prognosis. In septic
and non septic patients, PCT levels were found to be
highly predictive for mortality and organ failure develop-
ment[1,9,11,19]. During cardiac arrest delivery of oxygen
is abruptly halted. After recovery of spontaneous circula-
tion, ischemia/reperfusion syndrome causes an early sys-
temic inflammatory response, leading to an exacerbation
of the inflammatory balance, and may possibly be associ-
ated with an endotoxin tolerance. This condition has
many features in common with sepsis. Plasma levels of
various cytokines, soluble receptors, and endotoxin were
associated with outcome after cardiac arrest [15]. PCT isPage 3 of 6
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Correlation between time of cardiac arrest (CRA) and time to initiation of cardiopulmonary resuscitation (CPR) with procalci-tonin (PCT) values at 24 hFigure 3
Correlation between time of cardiac arrest (CRA) and time to initiation of cardiopulmonary resuscitation 
(CPR) with procalcitonin (PCT) values at 24 h.
Box-plot of CRP plasma concentrations in the different groupsFigure 2
Box-plot of CRP plasma concentrations in the different groups. Data are presented in a logarithmic scale Central line: 
median; boxes: 25th to 75th percentiles; whiskers: 95% confidence.
BMC Pediatrics 2008, 8:18 http://www.biomedcentral.com/1471-2431/8/18Correlation between time of cardiac arrest (CRA) and time to initiation of cardiopulmonary resuscitation (CPR) with C reac-tive pro ei (CRP) values at 24 hFigure 4
Correlation between time of cardiac arrest (CRA) and time to initiation of cardiopulmonary resuscitation 
(CPR) with C reactive protein (CRP) values at 24 h.
produced in the liver and other tissues following activa-
tion by mononuclear cells[20]. A PCT production is also
reported in shock situations[2,8,19,21], after surgery and
tissue trauma[22]. Cardiac arrest is the most severe shock
situation in a critical child. In all our children, survivors
and non-survivors, PCT and CRP levels increased at 12
and 24 hours after cardiac arrest, confirming that both
markers are elevated in patients with shock. PCT increase
has been described after cardiac arrest in adults[23,24].
Comparing both groups, non-survivors maintained PCT
increase between 12 and 24 hours whereas survivors did
not increase PCT levels. This could indicate that non sur-
vivor patient's present a more severe shock with more
severe tissue damage, hypoxemia and reperfusion injury,
associated with longer time of cardiac arrest, mortality
and PCT increase. In our patients, time of cardiac arrest
and time to initiation of CPR were correlated with PCT
values at 24 h. We did not find this quality for CRP.
Another important finding is that PCT elevation is not
directly related with infection in these cases. According
with the literature, cut-off PCT values for diagnosis of bac-
terial infections are between 0.5 and 5.0 ng/mL whereas
cut-off values for diagnosis of shock are much
higher[1,5,18]. Splanchnic hypoperfursion after cardiac
arrest as well as reperfusion injury can cause mucosal bar-
rier damage permitting translocation of endotoxin to the
bloodstream and increasing PCT to the high values
detected in our patients.
The main limitation of our study is the small number of
patients. Because cardiac arrest is uncommon in paediat-
ric age a multicenter study could be necessary to have a
bigger sample.
Conclusion
Measurement of PCT during the first 24 hours after paedi-
atric cardiac arrest can predict non survival of patients.
PCT values higher than 100 ng/mL 24 hours after cardiac
arrest could serve as marker of mortality. CRP did not
show this quality.
Abbreviations
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